What's behind the weight loss drug name Zepbound?

The story behind Zepbound offers insight into the marketing differences between the U.S. and Europe, and how drug names are developed.

November 20, 2023 Check out STAT+

Sponsored By

Photo illustration Christine Kao/STAT; Adobe Respiratory viruses, thrown out of whack by Covid, appear to be falling back into seasonal order The usual pattern of viruses, disrupted by the Covid-19 pandemic and the measures we took to avoid disease, seems largely back on track. By Helen Branswell STAT+ | CRISPR's pioneers reflect on the first gene-editing treatment Jennifer Doudna, Emmanuelle Charpentier, Feng Zhang, and George Church reflect on the approval of Casgevy, the first CRISPR-based drug. By Matthew Herper STAT+ | How a major hospital shows just how inflated hospital list prices are Hospitals' list prices always come with massive discounts. Financial documents at Cedars-Sinai in LA show just how large those discounts are. By Bob Herman Illustration: STAT; Source: Eli Lilly/AP STAT+ | What Eli Lilly's Zepbound reveals about the intricate process of naming drugs today Marketing the same drug with two names is not unheard of: Prozac and Sarafem, Latisse and Lumigan, Eylea and Zaltrap. Here's why it happens. By Annalisa Merelli STAT+ | Hospitals put tech spending on a tight leash, raise the bar for pilots Hospitals are increasingly cautious about tech spending, insisting that new products demonstrate concrete, measurable benefits to patients. By Mohana Ravindranath Opinion: The FDA is at a crossroads on cell and gene therapies Former Sen. Richard Burr: "The FDA has an opportunity to transform its oversight of cell and gene therapies and deliver on promises made." By Richard Burr

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser